entertainment -WSS

entertainment

author：focus 2025-10-01 22:57:18 - browse：3

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Printout prescription drug information shouldn’t go digital

WSS

Prior authorization reform is both possible and imperative

Feed a cold, starve a fever? Here’s what science says

To bolster infectious disease surveillance, genomics powerhouses team up

To bolster infectious disease surveillance, genomics powerhouses team up

With heat waves through August, officials warn of health risks

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Alkermes shareholders re

Flash flood warnings continue for parts of Missouri, Illinois

Hollywood unions extend contract negotiations for actors

Doctors push to include dialysis machines in emergency stockpile

Heart attack and stroke risk calculators need revising

Restaurant meals are packed with calories, and we still keep eating them

Jerome Adams on the need for new antivirals for Covid

Mass General, Mayo Clinic look to monetize custom

Medical leaders decry Supreme Court decision on affirmative action

Doctors push to include dialysis machines in emergency stockpile

focus

FDA sets aggressive timeline for overhauling inspection procedures

Prior authorization reform is both possible and imperative

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Medicare drug price lawsuits could be good politics for Biden

To bolster infectious disease surveillance, genomics powerhouses team up

What causes osteoarthritis? Researchers study link to brain protein

Wikipedia

hotspot

focus

focus